Karen Beatty, LPN.; The Petitioner seeks the Board=s interpretation of the application of Section 464.003, F.S. and Chapter 64B9-12, F.A.C. Specifically, the Petitioner requests that the Board issue a Declaratory Statement determining under the ...

 

DEPARTMENT OF HEALTH
Division of Medical Quality Assurance

Board of Nursing

NOTICE IS HEREBY GIVEN THAT Board of Nursing has received the petition for declaratory statement from Karen Beatty, LPN. The petition seeks the agency’s opinion as to the applicability of Section 464.003, F.S. and Chapter 64B9-12, F.A.C., as it applies to the petitioner.

The Petitioner seeks the Board’s interpretation of the application of Section 464.003, F.S. and Chapter 64B9-12, F.A.C. Specifically, the Petitioner requests that the Board issue a Declaratory Statement determining under the provisions of Section 464.003, F.S. and Chapter 64B9-12, F.A.C., whether it is within the scope of practice for an LPN to perform in psychiatric treatment intramuscular injection of Haldol decanoate, Prolixin decanoate, and Risperdal Consta to patients in their homes without an RN or MD present directly on the premises but available immediately by cell phone. This petition will be considered at the April 2007 meeting of the Board.

A copy of the Petition for Declaratory Statement may be obtained by contacting: Rick Garcia, Executive Director, Board of Nursing, 4052 Bald Cypress Way, Bin #C07, Tallahassee, Florida 32399-3259.

Please refer all comments to: Rick Garcia, Executive Director, Board of Nursing, 4052 Bald Cypress Way, Bin #C07, Tallahassee, Florida 32399-3259.